tradingkey.logo

Adapthealth Corp

AHCO
查看詳細走勢圖
10.250USD
+0.010+0.10%
收盤 12/26, 16:00美東報價延遲15分鐘
1.39B總市值
18.30本益比TTM

Adapthealth Corp

10.250
+0.010+0.10%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.10%

5天

+2.81%

1月

+6.66%

6月

+8.81%

今年開始到現在

+7.67%

1年

+4.70%

查看詳細走勢圖

TradingKey Adapthealth Corp股票評分

單位: USD 更新時間: 2025-12-26

操作建議

Adapthealth Corp當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名17/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價13.25。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Adapthealth Corp評分

相關信息

行業排名
17 / 207
全市場排名
89 / 4563
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 8 分析師
買入
評級
13.250
目標均價
+41.11%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Adapthealth Corp亮點

亮點風險
AdaptHealth Corp. is a provider of patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. It operates in 50 states through its network of over 670 locations in 47 states.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入3.26B美元
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值18.30,處於3年歷史高位
機構加倉
最新機構持股140.93M股,環比增加0.01%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉714.00股

Adapthealth Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Adapthealth Corp簡介

AdaptHealth Corp. is a provider of patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. It operates in 50 states through its network of over 670 locations in 47 states.
公司代碼AHCO
公司Adapthealth Corp
CEOFoster (Suzanne M)
網址https://adapthealth.com/investor-relations/

常見問題

Adapthealth Corp(AHCO)的當前股價是多少?

Adapthealth Corp(AHCO)的當前股價是 10.250。

Adapthealth Corp 的股票代碼是什麼?

Adapthealth Corp的股票代碼是AHCO。

Adapthealth Corp股票的52週最高點是多少?

Adapthealth Corp股票的52週最高點是11.630。

Adapthealth Corp股票的52週最低點是多少?

Adapthealth Corp股票的52週最低點是7.105。

Adapthealth Corp的市值是多少?

Adapthealth Corp的市值是1.39B。

Adapthealth Corp的淨利潤是多少?

Adapthealth Corp的淨利潤為82.75M。

現在Adapthealth Corp(AHCO)的股票是買入、持有還是賣出?

根據分析師評級,Adapthealth Corp(AHCO)的總體評級為買入,目標價格為13.250。

Adapthealth Corp(AHCO)股票的每股收益(EPS TTM)是多少

Adapthealth Corp(AHCO)股票的每股收益(EPS TTM)是0.560。
KeyAI